Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN).

GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN).

Resource Type

CF Research News

Authors

van Koningsbruggen-Rietschel S, Conrath K, Fischer R, Sutharsan S, Kempa A, Gleiber W, Schwarz C, Hector A, Van Osselaer N, Pano A, Corveleyn S, Bwirire D, Santermans E, Muller K, Bellaire S, Van de Steen O

References

J Cyst Fibros. 2019 Oct 5. pii: S1569-1993(19)30890-2. doi: 10.1016/j.jcf.2019.09.006.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR corrector [3]
Combination therapy [4]
Efficacy [5]
GLPG2737 [6]
Ivacaftor [7]
Lumacaftor [8]

Date

Saturday, October 5, 2019

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [9]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/glpg2737-lumacaftorivacaftor-treated-cf-subjects-homozygous

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00221R2_FINAL_Koningsbruggen_081119.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=GLPG2737%20IN%20LUMACAFTOR/IVACAFTOR-TREATED%20CF%20SUBJECTS%20HOMOZYGOUS%20FOR%20THE%20F508DEL%20MUTATION%3A%20A%20RANDOMIZED%20PHASE%202A%20TRIAL%20%28PELICAN%29 [3] https://www.ecfs.eu/research-article-keywords/cftr-corrector [4] https://www.ecfs.eu/research-article-keywords/combination-therapy [5] https://www.ecfs.eu/research-article-keywords/efficacy [6] https://www.ecfs.eu/research-article-keywords/glpg2737 [7] https://www.ecfs.eu/research-article-keywords/ivacaftor [8] https://www.ecfs.eu/research-article-keywords/lumacaftor [9] https://www.ecfs.eu/resource-guideline-type/other-guidelines